A randomized cross-over study comparing cabergoline and quinagolide in the treatment of hyperprolactinemic patients.


Quinagolide (QUI) and cabergoline (CAB) are dopamine agonists recently introduced for the treatment of hyperprolactinemia. In the present study, these drugs have been compared in terms of effectiveness and tolerability. Twenty patients (18 females and 2 males) with hyperprolactinemia (8 with microprolactinomas, 6 with idiopathic hyperprolactinemia and 6… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.